| 000 | 01722 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514005055.0 | ||
| 264 | 0 | _c20011004 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0735-1097 | ||
| 024 | 7 |
_a10.1016/s0735-1097(01)01402-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWyse, D G | |
| 245 | 0 | 0 |
_aAntiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cAug 2001 |
||
| 300 |
_a344-51 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTachycardia, Ventricular _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xcomplications |
| 700 | 1 | _aTalajic, M | |
| 700 | 1 | _aHafley, G E | |
| 700 | 1 | _aBuxton, A E | |
| 700 | 1 | _aMitchell, L B | |
| 700 | 1 | _aKus, T K | |
| 700 | 1 | _aPacker, D L | |
| 700 | 1 | _aKou, W H | |
| 700 | 1 | _aLemery, R | |
| 700 | 1 | _aSantucci, P | |
| 700 | 1 | _aGrimes, D | |
| 700 | 1 | _aHickey, K | |
| 700 | 1 | _aStevens, C | |
| 700 | 1 | _aSingh, S N | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 38 _gno. 2 _gp. 344-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0735-1097(01)01402-4 _zAvailable from publisher's website |
| 999 |
_c11424948 _d11424948 |
||